Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction : GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials
Journal article
Teerlink, John R., Diaz, Rafael, Felker, G. Michael, McMurray, John J. V., Metra, Marco, Solomon, Scott D., Adams, Kirkwood F., Anand, Inder, Arias-Mendoza, Alexandra, Biering-Sørensen, Tor, Böhm, Michael, Bonderman, Diana, Cleland, John G. F., Corbalan, Ramon, Crespo-Leiro, Maria G., Dahlström, Ulf, Echeverria Correa, Luis E., Fang, James C., Filippatos, Gerasimos, ... GALACTIC-HF Investigators. (2020). Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction : GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials. European Journal of Heart Failure. 22(11), pp. 2160-2171. https://doi.org/10.1002/ejhf.2015
Authors | Teerlink, John R., Diaz, Rafael, Felker, G. Michael, McMurray, John J. V., Metra, Marco, Solomon, Scott D., Adams, Kirkwood F., Anand, Inder, Arias-Mendoza, Alexandra, Biering-Sørensen, Tor, Böhm, Michael, Bonderman, Diana, Cleland, John G. F., Corbalan, Ramon, Crespo-Leiro, Maria G., Dahlström, Ulf, Echeverria Correa, Luis E., Fang, James C., Filippatos, Gerasimos, Fonseca, Cândida, Goncalvesova, Eva, Goudev, Assen R., Howlett, Jonathan G., Lanfear, David E., Lund, Mayanna, Macdonald, Peter, Mareev, Vyacheslav, Momomura, Shin-ichi, O'Meara, Eileen, Parkhomenko, Alexander, Ponikowski, Piotr, Ramires, Felix J. A., Serpytis, Pranas, Sliwa, Karen, Spinar, Jindrich, Suter, Thomas M., Tomcsanyi, Janos, Vandekerckhove, Hans, Vinereanu, Dragos, Voors, Adriaan A., Yilmaz, Mehmet B., Zannad, Faiez, Sharpsten, Lucie, Legg, Jason C., Abbasi, Siddique A., Varin, Claire, Malik, Fady I., Kurtz, Christopher E. and GALACTIC-HF Investigators |
---|---|
Abstract | Aims Methods and results Conclusions |
Keywords | heart failure; omecamtiv mecarbil; cardiac myosin activator; inotrope; myotrope; cardiovascular outcomes trial |
Year | 2020 |
Journal | European Journal of Heart Failure |
Journal citation | 22 (11), pp. 2160-2171 |
Publisher | John Wiley & Sons |
ISSN | 1388-9842 |
Digital Object Identifier (DOI) | https://doi.org/10.1002/ejhf.2015 |
Scopus EID | 2-s2.0-85093930981 |
Open access | Published as ‘gold’ (paid) open access |
Research or scholarly | Research |
Page range | 2160-2171 |
Funder | Amgen, Inc. |
Cytokinetics | |
Servier | |
Publisher's version | License File Access Level Open |
Output status | Published |
Publication dates | |
Online | 27 Sep 2020 |
Publication process dates | |
Accepted | 20 Sep 2020 |
Deposited | 06 Jul 2021 |
https://acuresearchbank.acu.edu.au/item/8w51z/omecamtiv-mecarbil-in-chronic-heart-failure-with-reduced-ejection-fraction-galactic-hf-baseline-characteristics-and-comparison-with-contemporary-clinical-trials
Download files
Publisher's version
OA_Teerlink_2020_Omecamtiv_Mecarbil_in_chronic_heart_failure.pdf | |
License: CC BY-NC 4.0 | |
File access level: Open |
163
total views50
total downloads5
views this month1
downloads this month